The former managers of the Icelandic commercial banks and the Central Bank of Iceland were yesterday awarded the Ig Nobel Prize for Economics at Harvard University in the USA. Read the full story

Actavis, a generic pharmaceuticals company based in Iceland, last week announced that Harvard Business School had produced a case study on the company and its president and CEO, Robert Wessman.

The study, entitled “Robert Wessman and Actavis’ ‘Winning formula’” was presented in an MBA class in international entrepreneurship at Harvard and will be made available to business schools around the world.

Dr Daniel Isenberg, Senior Lecturer of Business Administration, created the case study to show how a relatively small Icelandic pharmaceutical company became one of the world’s largest producers of generic pharmaceuticals, lead by 39 year-old CEO Robert Wessman.

Robert Wessman participated in extensive interviews with Dr Isenberg to develop the study, providing financial data as well as historical and personal information. He was also class guest for the case debut on 22 April where he answered numerous questions from the students who asked about a variety of topics, including the Actavis way of doing business and the CEO’s leadership style.

Read the full story